NLRP3 and COVID-19: Our results revealed that exosomes from severe COVID-19 patients trigger (i) NLRP3, caspase-1, and IL-1β transcription; (ii) NLRP3 inflammasome activation; and (iii) maturation and secretion of IL-1β from endothelial cells.